Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Blocks for Analgesia Following Posterior Spinal Fusion
NCT07228039Phase 4Recruiting
- Sponsor
- Duke University
- Start
- Sep 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine, sponsored by Duke University. Started Sep 2026; status: recruiting.
02
Drugs
liposomal bupivacaine
Beyond the preview
Go deeper on NCT07228039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07228039.